2.27 USD
↘ 0.02 (0.87%)AT CLOSE (11:59 AM EDT)
XBiotech Inc
XBITNASDAQ • USD
2.30
↗ 0.03 (1.28%)
POST MARKET (AS OF 05:24 PM EDT)
Post Market
AS OF 05:24 PM EDT
2.30
↗ 0.03 (1.28%)
Market: OPEN
Shares of XBiotech Inc (XBIT) are trading at $2.30. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, XBIT appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Jul 17, 2026.
Open?$2.28
High?$2.28
Low?$2.25
Prev. Close?$2.29
Volume?59.1K
Avg. Volume?32.8K
VWAP?$2.28
Rel. Volume?1.80x
Bid / Ask
Bid?$1.96 × 100
Ask?$2.60 × 100
Spread?$0.64
Midpoint?$2.28
Valuation & Ratios
Market Cap?69.8M
Shares Out?30.5M
Float?16.7M
Float %?54.8%
P/E Ratio?N/A
P/B Ratio?0.52
EPS?-$1.32
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
Themes
Employees
87
Market Cap
69.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2015-04-15
Address
5217 WINNEBAGO LANE
AUSTIN, TX 78744
Phone: 512-386-2900
AUSTIN, TX 78744
Phone: 512-386-2900
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?41
Piotroski F-Score?0/9Weak
Altman Z-Score?7.11Safe
Confidence?40%Low
Short InterestHigh
Short % of Float?1.65%Low
Short Interest?275.6K
Days to Cover?8.5
Free Float16.7M
Avg Daily Volume32.5K
Settlement Date2026-06-30
Financial Health
Current Ratio?39.03Strong
Quick Ratio?39.03Strong
Cash Ratio?38.50Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.52CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?1.0CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-29.8%WEAK▾
S&P6
ROA?-28.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-42364000
Enterprise Value?$-45642096
Fundamentals ratios updated end of day